Every SEC Form 3/4/5 on record for this filer (CIK 1722050) — 8 issuers, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 10% owner · lapsed | 2023-11-02 → 2023-11-09 | 2 | — |
| THRX | Theseus Pharmaceuticals, Inc. | Filer · lapsed | 2021-10-06 → 2021-10-14 | 2 | — |
| NUVB | Nuvation Bio Inc. | 10% owner · lapsed | 2021-02-12 → 2021-02-12 | 2 | — |
| KRON | Kronos Bio, Inc. | 10% owner · lapsed | 2020-10-08 → 2020-10-16 | 2 | $9M |
| MORF | Morphic Holding, Inc. | 10% owner · lapsed | 2019-06-26 → 2019-07-01 | 2 | — |
| IMUX | IMMUNIC, INC. | 10% owner · lapsed | 2019-04-22 → 2019-04-22 | 1 | — |
| TBIO | Translate Bio, Inc. | 10% owner · lapsed | 2018-06-27 → 2018-07-03 | 2 | — |
| ASNS | ACTELIS NETWORKS INC | Director · lapsed | 2017-11-15 → 2018-06-07 | 5 | $3M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KRON | 2020-10-14 | Buy | 450,000 | $19.00 | $9M | 3,818,283 |
| ASNS | 2017-11-20 | Buy | 300,000 | $10.00 | $3M | 867,639 |
4 of 8 issuers are covered and open a security page; the rest are on file here only.
